Trials / Completed
CompletedNCT04080856
Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada
Real-World Experience of Elagolix For the Treatment of Endometriosis in Canada: An Observational Cohort Study (GRACE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate real-world effectiveness of elagolix in Canadian women with endometriosis.
Conditions
Timeline
- Start date
- 2019-12-04
- Primary completion
- 2021-09-27
- Completion
- 2021-09-27
- First posted
- 2019-09-06
- Last updated
- 2022-09-28
Locations
18 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT04080856. Inclusion in this directory is not an endorsement.